Litigation Details for GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2017)
✉ Email this page to a colleague
GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-12-20 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 15:1126 Patent Infringement | Assigned To | |
Jury Demand | Plaintiff | Referred To | |
Patents | 7,381,560; 7,485,704; 7,807,799; 7,820,161; 7,976,838; 8,206,711; 8,329,172; 8,512,983; 8,545,843; 8,557,244; 8,821,873; 9,296,821; 9,504,744; 9,714,293 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in GENENTECH, INC. v. SANDOZ, INC.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-12-20 | 1 | U.S. Patent No. 7,381,560 81. U.S. Patent No. 7,381,560 (“the ’560 patent”) is entitled… COUNT VII (INFRINGEMENT OF U.S. PATENT NO. 7,381,560 UNDER 35 U.S.C. § 271(E)(2)) …DECLARATORY JUDGMENT OF INFRINGEMENT OF U.S. PATENT NO. 7,381,560) 540. Plaintiffs re-allege … U.S. Patent No. 6,121,428 69. U.S. Patent No. 6,121,428 (“the ’428 patent”) is entitled… U.S. Patent No. 6,331,415 71. U.S. Patent No. 6,331,415 (“the ’415 patent”) is entitled | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |